Midline brain hamartomatous lesions in fibrodysplasia ossificans progressiva with ACVR1 mutations

被引:0
作者
Kresak, Jesse Lee [1 ]
Walsh, Meggen [1 ]
Tuzzolo, Anthony [1 ]
Ordulu, Zehra [1 ]
Gregory, Jason [1 ]
机构
[1] Univ Florida, Dept Pathol Immunol & Lab Med, 1600 SW Archer Rd,POB 100275, Gainesville, FL 32618 USA
关键词
ACVR1; brainstem; diffuse intrinsic pontine glioma; fibrodysplasia ossificans progressiva; hamartoma; JOINT-CONSENSUS-RECOMMENDATION; INTRINSIC PONTINE GLIOMAS; GENOMIC LANDSCAPE; SEQUENCE VARIANTS; ASSOCIATION; GUIDELINES; SUBGROUPS; STANDARDS; GENETICS; COLLEGE;
D O I
10.1111/neup.12892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disorder characterized by extensive heterotopic ossification of soft tissue structures leading to severe limitations in movement. FOP is caused by a germline mutation in the activating receptor type IA (ACVR1) gene. Worrisome is the fact that up to a third of diffuse intrinsic pontine gliomas (DIPG) also harbor the same point mutation in ACVR1. Radiological reports of central nervous system (CNS) involvement by FOP have described brainstem masses; however, the literature on the histopathology or pathogenesis of these lesions is scant. Here we present detailed neuropathologic findings of a brainstem mass in a patient with FOP and suggest that the tumor is hamartomatous in nature. This report, along with a literature review of radiographic and laboratory data, offers support for the idea that the ACVR1 mutation may incite CNS proliferation, predominantly in the brainstem, but is probably not an oncologic driver. These lesions may be seen at autopsy and are likely noncontributory to death.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 27 条
  • [1] [Anonymous], 2021, World Health Organization Classification of Tumours of the Central Nervous System, DOI DOI 10.1016/J.CHEST.2016.10.010
  • [2] New insights into central nervous system involvement in FOP: Case report and review of the literature
    Bertamino, Marta
    Severino, Mariasavina
    Schiaffino, Maria Cristina
    Garre, Maria Luisa
    Bocciardi, Renata
    Ravazzolo, Roberto
    Rossi, Andrea
    Di Rocco, Maja
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (11) : 2817 - 2821
  • [3] Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
    Buczkowicz, Pawel
    Hoeman, Christine
    Rakopoulos, Patricia
    Pajovic, Sanja
    Letourneau, Louis
    Dzamba, Misko
    Morrison, Andrew
    Lewis, Peter
    Bouffet, Eric
    Bartels, Ute
    Zuccaro, Jennifer
    Agnihotri, Sameer
    Rya, Scott
    Barszczyk, Mark
    Chornenkyy, Yevgen
    Bourgey, Mathieu
    Bourque, Guillaume
    Montpetit, Alexandre
    Cordero, Francisco
    Castelo-Branco, Pedro
    Mangere, Joshua
    Tabori, Uri
    Ching, King
    Huang, Annie
    Taylor, Kathryn R.
    Mackay, Alan
    Bendell, Anne E.
    Nazarian, Javad
    Fangusaro, Jason R.
    Karajannis, Matthias A.
    Zagzag, David
    Foreman, Nicholas K.
    Donson, Andrew
    Hegert, Julia V.
    Smith, Amy
    Chan, Jennifer
    Lafay-Cousin, Lucy
    Dunn, Sandra
    Hukin, Juliette
    Dunham, Chris
    Scheinemann, Katrin
    Michaud, Jean
    Zelcer, Shayna
    Ramsay, David
    Cain, Jason
    Brennan, Cameron
    Souweidane, Mark M.
    Jones, Chris
    Allis, C. David
    Brudno, Michael
    [J]. NATURE GENETICS, 2014, 46 (05) : 451 - 456
  • [4] Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
    Castel, David
    Philippe, Cathy
    Calmon, Raphael
    Le Dret, Ludivine
    Truffaux, Nathalene
    Boddaert, Nathalie
    Pages, Melanie
    Taylor, Kathryn R.
    Saulnier, Patrick
    Lacroix, Ludovic
    Mackay, Alan
    Jones, Chris
    Sainte-Rose, Christian
    Blauwblomme, Thomas
    Andreiuolo, Felipe
    Puget, Stephanie
    Grill, Jacques
    Varlet, Pascale
    Debily, Marie-Anne
    [J]. ACTA NEUROPATHOLOGICA, 2015, 130 (06) : 815 - 827
  • [5] Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
    Han, Harry J.
    Jain, Payal
    Resnick, Adam C.
    [J]. BONE, 2018, 109 : 91 - 100
  • [6] ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant
    Haupt, Julia
    Deichsel, Alexandra
    Stange, Katja
    Ast, Cindy
    Bocciardi, Renata
    Ravazzolo, Roberto
    Di Rocco, Maja
    Ferrari, Paola
    Landi, Antonio
    Kaplan, Frederick S.
    Shore, Eileen M.
    Reissner, Carsten
    Seemann, Petra
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 (20) : 5364 - 5377
  • [7] CNS demyelination in fibrodysplasia ossificans progressiva
    Kan, Lixin
    Kitterman, Joseph A.
    Procissi, Daniele
    Chakkalakal, Salin
    Peng, Chian-Yu
    McGuire, Tammy L.
    Goldsby, Robert E.
    Pignolo, Robert J.
    Shore, Eileen M.
    Kaplan, Frederick S.
    Kessler, John A.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (12) : 2644 - 2655
  • [8] Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva
    Khan, Fatima
    Yu, Xiaobing
    Hsiao, Edward C.
    [J]. BIOMEDICINES, 2021, 9 (02) : 1 - 15
  • [9] Neurological symptoms in individuals with fibrodysplasia ossificans progressiva
    Kitterman, Joseph A.
    Strober, Jonathan B.
    Kan, Lixin
    Rocke, David M.
    Cali, Amanda
    Peeper, Jeannie
    Snow, Jennifer
    Delai, Patricia L. R.
    Morhart, Rolf
    Pignolo, Robert J.
    Shore, Eileen M.
    Kaplan, Frederick S.
    [J]. JOURNAL OF NEUROLOGY, 2012, 259 (12) : 2636 - 2643
  • [10] Teaching NeuroImages: MRI in fibrodysplasia ossificans progressiva
    Kumar, Shiva R.
    Keerthiraj, B.
    Kesavadas, Chandrasekhran
    [J]. NEUROLOGY, 2010, 74 (06) : E20 - E20